Government, Alexion spar over Soliris
Published: 2012-05-11 06:57:00
Updated: 2012-05-11 06:57:00
The Korean government and Alexion Pharmaceuticals, the drug maker that exclusively manufactures Soliris (eculizumab), are walking a tightrope not to irritate each other, but their conflicting needs continue to put them at odds over the possible supply of the drug.
Soliris is used to treat paro...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
